• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎病毒感染与骨密度的关系。

Association between chronic hepatitis C virus infection and bone mineral density.

机构信息

Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.

出版信息

Calcif Tissue Int. 2012 Dec;91(6):423-9. doi: 10.1007/s00223-012-9653-y. Epub 2012 Oct 5.

DOI:10.1007/s00223-012-9653-y
PMID:23052227
Abstract

Whether chronic hepatitis C virus (HCV) infection is a risk factor for the development of bone disease has long been controversial. For this reason, chronic HCV-infected participants (n = 69) were recruited into a prospective cohort study and underwent dual-energy X-ray absorptiometry for determination of bone mineral density (BMD). Fibrosis staging was evaluated according to the noninvasive index FIB-4. T scores at the femoral neck and lumbar spine were used as the primary outcome variables to assess the association between degree of liver disease and BMD. The study cohort was 41 % male with a mean age of 53.6 years. The mean BMD, Z score, and T score values of lumbar spine in chronic hepatitis C (CHC) patients were significantly lower than those in healthy controls (p < 0.001). The rate of osteoporosis for CHC patients aged 45-54 years was significantly higher than that of the control group (p = 0.011). Bone alkaline phosphatase and C-terminal cross-linking telopeptide of type I collagen levels were also significantly higher in CHC patients with reduced BMD. Patients with more advanced liver fibrosis had significantly lower BMD. In conclusion, reduced BMD is common in this population of chronic HCV-infected patients and associated with liver disease severity. This extrahepatic manifestation is probably secondary to increased bone turnover in osteodystrophy pathogenesis.

摘要

慢性丙型肝炎病毒(HCV)感染是否是骨病发展的危险因素一直存在争议。出于这个原因,招募了 69 名慢性 HCV 感染的参与者(n=69)进入前瞻性队列研究,并进行双能 X 射线吸收法测定骨矿物质密度(BMD)。纤维化分期根据无创指数 FIB-4 进行评估。股骨颈和腰椎的 T 评分作为主要观察指标,用于评估肝脏疾病严重程度与 BMD 的关系。研究队列中 41%为男性,平均年龄为 53.6 岁。慢性丙型肝炎(CHC)患者腰椎的平均 BMD、Z 评分和 T 评分明显低于健康对照组(p<0.001)。45-54 岁 CHC 患者的骨质疏松症发生率明显高于对照组(p=0.011)。BMD 降低的 CHC 患者的骨碱性磷酸酶和 I 型胶原 C 端交联肽水平也明显升高。肝纤维化程度更严重的患者的 BMD 明显降低。总之,在这群慢性 HCV 感染患者中,BMD 降低很常见,且与肝脏疾病的严重程度相关。这种肝外表现可能继发于骨质疏松症发病机制中骨转换的增加。

相似文献

1
Association between chronic hepatitis C virus infection and bone mineral density.慢性丙型肝炎病毒感染与骨密度的关系。
Calcif Tissue Int. 2012 Dec;91(6):423-9. doi: 10.1007/s00223-012-9653-y. Epub 2012 Oct 5.
2
Areal bone mineral density in pediatric patients with chronic hepatitis B or chronic hepatitis C.慢性乙型肝炎或慢性丙型肝炎患儿的区域骨矿物质密度
Calcif Tissue Int. 2014 Sep;95(3):218-21. doi: 10.1007/s00223-014-9884-1. Epub 2014 Jun 24.
3
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.终末期肺病肺移植候选者中的骨质疏松症
Am J Med. 1996 Sep;101(3):262-9. doi: 10.1016/S0002-9343(96)00155-6.
4
Femoral neck osteopenia in patients with inflammatory bowel disease.炎症性肠病患者的股骨颈骨质减少
Am J Gastroenterol. 1998 Sep;93(9):1483-90. doi: 10.1111/j.1572-0241.1998.468_q.x.
5
Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.在 HIV/HCV 合并感染中,与低骨密度相关的是 HIV 病毒的控制复制,而不是肝脏疾病的严重程度。
J Hepatol. 2011 Oct;55(4):770-6. doi: 10.1016/j.jhep.2011.01.035. Epub 2011 Feb 19.
6
The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.胰岛素样生长因子 1、胰岛素样生长因子结合蛋白 3 及骨密度在埃及开罗慢性丙型肝炎病毒患者中的潜在作用。
Trans R Soc Trop Med Hyg. 2010 Jun;104(6):429-32. doi: 10.1016/j.trstmh.2010.01.012. Epub 2010 Mar 1.
7
Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.尿中Ⅰ型胶原交联N-端肽水平升高预示炎症性肠病患者骨质流失。
Am J Gastroenterol. 2000 Mar;95(3):699-704. doi: 10.1111/j.1572-0241.2000.01850.x.
8
Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.高胆红素血症并非慢性肝病患者骨矿物质密度改变的主要促成因素。
J Clin Densitom. 2006 Jan-Mar;9(1):105-13. doi: 10.1016/j.jocd.2005.10.001. Epub 2006 Mar 27.
9
Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C.慢性丙型肝炎非肝硬化患者的骨矿物质密度、骨转换和全身炎症
Dig Dis Sci. 2015 Jun;60(6):1813-9. doi: 10.1007/s10620-014-3507-6. Epub 2015 Jan 7.
10
Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.非肝硬化慢性乙型或丙型肝炎感染患者的骨矿物质密度降低及骨转换标志物改变。
World J Gastroenterol. 2005 Mar 28;11(12):1843-7. doi: 10.3748/wjg.v11.i12.1843.

引用本文的文献

1
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines.慢性丙型肝炎感染中异常的小梁骨和皮质骨微结构及其与特定炎性细胞因子的关联
Open Forum Infect Dis. 2025 Apr 29;12(5):ofaf102. doi: 10.1093/ofid/ofaf102. eCollection 2025 May.
2
Association of chronic liver disease with bone diseases and muscle weakness.慢性肝病与骨骼疾病和肌肉无力的关联。
J Bone Miner Metab. 2024 Jul;42(4):399-412. doi: 10.1007/s00774-023-01488-x. Epub 2024 Feb 1.
3
Risk factors for fractures following liver transplantation: a population-based cohort study.
肝移植后骨折的风险因素:基于人群的队列研究。
Ann Med. 2023 Dec;55(1):2230871. doi: 10.1080/07853890.2023.2230871.
4
Seropositive for hepatitis B and C viruses is associated with the risk of decreased bone mineral density in adults: An analysis of studies from the NHANES database.乙肝和丙肝病毒血清学阳性与成人骨矿物质密度降低风险相关:来自美国国家健康和营养检查调查(NHANES)数据库的研究分析
Front Med (Lausanne). 2023 Mar 22;10:1120083. doi: 10.3389/fmed.2023.1120083. eCollection 2023.
5
Unravelling hip-spine bone mineral density discordance in people living with HIV.解析感染HIV人群的髋部与脊柱骨密度不一致情况。
J Bone Miner Metab. 2022 Nov;40(6):990-997. doi: 10.1007/s00774-022-01365-z. Epub 2022 Aug 29.
6
Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection.维生素D状态与细胞因子之间的关系:初治非肝硬化慢性丙型肝炎感染患者基于干扰素治疗的结果
J Inflamm Res. 2020 Dec 29;13:1207-1218. doi: 10.2147/JIR.S283768. eCollection 2020.
7
Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development.肝性骨营养不良-有利于其发展的分子机制。
Int J Mol Sci. 2019 May 24;20(10):2555. doi: 10.3390/ijms20102555.
8
Bone Health and Impact of Tenofovir Treatment in Men with Hepatitis-B Related Chronic Liver Disease.骨健康及替诺福韦治疗对乙型肝炎相关慢性肝病男性患者的影响
J Clin Exp Hepatol. 2018 Mar;8(1):23-27. doi: 10.1016/j.jceh.2017.05.009. Epub 2017 May 15.
9
Hepatitis C virus infection and risk of osteoporosis: A meta-analysis.丙型肝炎病毒感染与骨质疏松症风险:一项荟萃分析。
Saudi J Gastroenterol. 2017 Jul-Aug;23(4):216-221. doi: 10.4103/sjg.SJG_452_16.
10
Bone health in HIV and hepatitis B or C infections.感染艾滋病毒及乙型或丙型肝炎时的骨骼健康
Ther Adv Musculoskelet Dis. 2017 Jan;9(1):22-34. doi: 10.1177/1759720X16671927. Epub 2016 Oct 7.